TCT-580 Novel Drug-Filled Coronary Stent and its Impact on Mechanical Attributes

Background A novel drug-filled coronary stent (DFS; Medtronic, Inc., Santa Rosa, CA) provides controlled drug elution from an internally-loaded drug platform without using a polymeric matrix, and thus may avoid chronic inflammation and adverse vascular responses associated with a polymer.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-10, Vol.66 (15), p.B235-B236
Main Authors: Foin, Nicolas, Goshgarian, Justin, Abizaid, Alexandre, Kirtane, Ajay J, Simon, Daniel, Windecker, Stephan, Worthley, Stephen G, Stone, Gregg W
Format: Article
Language:English
Subjects:
Angioplasty
Cardiology
Cardiovascular
Internal Medicine
Stents
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background A novel drug-filled coronary stent (DFS; Medtronic, Inc., Santa Rosa, CA) provides controlled drug elution from an internally-loaded drug platform without using a polymeric matrix, and thus may avoid chronic inflammation and adverse vascular responses associated with a polymer.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.1050